Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02162849 · ClinicalTrials.gov registry record · Phase 4

Reward Sensitivity and Pharmacotherapy for Smoking Cessation

A Phase 4 study of Tobacco Use Cessation, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
Phase 4
Development phase
204
Enrollment target
1
Study location

NCT02162849 is a Phase 4 study of Tobacco Use Cessation that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 204 participants, below the 879-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02162849, a Phase 4 study of Tobacco Use Cessation, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
204 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical research study is learn if varenicline or the nicotine patch can help people with different types of emotion and attention levels to quit smoking.

Conditions Studied

Tobacco Use Cessation

Interventions

  • BEHAVIORAL Questionnaires
  • DRUG Varenicline
  • DRUG Nicotine Patch
  • DRUG Placebo Patch
  • DRUG Placebo Tablet

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2015-12-14
Est. Completion 2028-02-28
Phase Phase 4

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02162849

The ClinicalTrials.gov registry entry for NCT02162849 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 879-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (77% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Use Cessation appearing as the primary indexed condition, and to 5 interventions - of which Questionnaires is the first listed.

NCT02162849 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02162849 about?

NCT02162849 is a clinical study titled "Reward Sensitivity and Pharmacotherapy for Smoking Cessation". The goal of this clinical research study is learn if varenicline or the nicotine patch can help people with different types of emotion and attention levels to quit smoking.

What is the current status of trial NCT02162849?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 204 participants. The study started on 2015-12-14. Estimated completion is 2028-02-28.

What conditions does trial NCT02162849 study?

This clinical trial studies the following conditions: Tobacco Use Cessation.

What interventions are being tested in trial NCT02162849?

The interventions under investigation include: Questionnaires (BEHAVIORAL), Varenicline (DRUG), Nicotine Patch (DRUG), Placebo Patch (DRUG), Placebo Tablet (DRUG).

Who is sponsoring clinical trial NCT02162849?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02162849 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Tobacco Use Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Tobacco Use Cessation

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.